Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Differential susceptibility of hair colour changes after barzolvolimab.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 04, 2026
On the Kinetics of Human Skin Mast Cell Depletion and Repopulation Following KIT Inhibition.
Journal: Allergy
Published: June 23, 2025
Anti-KIT Barzolvolimab for Chronic Spontaneous Urticaria.
Journal: Allergy
Published: January 13, 2025
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.
Journal: Cancers
Published: July 07, 2020
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 08, 2015
Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 01, 2014
Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 01, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026